Agenus | AGEN - Trade Creditors


Agenus reported $71.08M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agenus USD 71.08M 11.9M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celldex Therapeutics USD 10.36M 9.18M Mar/2026
CSL USD 3.17B 290M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 10.46B 1.53B Mar/2026
Jiangsu Hengrui CNY 2.33B 64.06M Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
MacroGenics USD 4.29M 500K Mar/2026
Merck EUR 2.13B 19M Mar/2026
Merck USD 3.86B 541M Mar/2026
Northwest Biotherapeutics 36.72M 9.49M Sep/2025
Novartis USD 4.32B 134M Mar/2026
Novavax USD 16.1M 8.48M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 6.91M 2.32M Mar/2026